Deloitte September 21, 2021

In brief

  • Survey of 100 biopharma business and IT executives across seven countries to capture insights into the adoption and use of emerging technologies.
  • Five emerging technology trends reveal that life sciences leaders must redefine how we work, live and interact to build a better future.
  • COVID-19 showed what is possible when tech is driven by a renewed sense of purpose and commitment to patients, customers and the general population.
  • 92% of biopharma execs agree that their organization’s business and technology strategies are becoming inseparable—even indistinguishable.

The when, where and how of care is changing. Rising costs of New Science and patient care, and the increase in demand for more holistic care models and experiences,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article